Table 3 Adverse events
From: Trace element supplementation in hemodialysis patients: a randomized controlled trial
Medium dose | Low dose | Medium and low dose combined | Standard dose | Exact P-value | |
|---|---|---|---|---|---|
Non-serious events | 7 (13.7) | 3 (6.4) | 10 (10.2) | 7 (14.3) | 0.59 |
Self-reported tremor | 0 (0) | 1 (2.1) | 1 (1.0) | 0 (0) | <0.99 |
Color and texture of fingernails | 3 (5.9) | 1 (2.1) | 4 (4.1) | 2 (4.1) | <0.99 |
Frequent vomiting | 0 (0) | 1 (2.1) | 1 (1.0) | 2 (4.1) | 0.26 |
Severe neutropenia | 3 (5.9) | 0 (0) | 3 (3.1) | 3 (6.1) | 0.40 |
Severe anemia | 1 (2.0) | 0 (0) | 1 (1.0) | 0 (0) | <0.99 |
Low copper status | 23 (50.0) | 22 (47.8) | 45 (48.9) | 27 (58.7) | 0.28 |
Serious events | |||||
Death | 0 (0) | 4 (8.5) | 4 (4.1) | 2 (3.9) | 0.65 |
Hospitalization1 | 8 (15.4) | 9 (19.2) | 17 (17.2) | 7 (13.7) | 0.79 |
Hospitalizations | 9 | 12 | 21 | 8 |